Using the expertise of leading ophthalmologists specializing in the most common refractive and non-refractive conditions, this program presents the latest therapies to protect the eyes in the event of potentially blinding diseases. Ivan Schwab, Director of Cornea and External Disease Service at the University of California, Davis, maps out the physiology of the eye and its role in sending images to the brain; Kuldev Singh, Director of the Glaucoma Service at Stanford University School of Medicine, describes the symptoms of glaucoma as well as the different therapies available; and Richard Abbot, clinical professor of ophthalmology at the University of California, San Francisco, describes macular degeneration and its contributing factors. (28 minutes).
"Using the expertise of leading ophthalmologists specializing in the most common refractive and non-refractive conditions, this program presents the latest therapies to protect the eyes in the event of potentially blinding diseases. Ivan Schwab, Director of Cornea and External Disease Service at the University of California, Davis, maps out the physiology of the eye and its role in sending images to the brain; Kuldev Singh, Director of the Glaucoma Service at Stanford University School of Medicine, describes the symptoms of glaucoma as well as the different therapies available; and Richard Abbot, clinical professor of ophthalmology at the University of California, San Francisco, describes macular degeneration and its contributing factors. (28 minutes)."@en
"Using the expertise of leading ophthalmologists specializing in the most common refractive and non-refractive conditions, this program presents the latest therapies to protect the eyes in the event of potentially blinding diseases. Ivan Schwab, Director of Cornea and External Disease Service at the University of California, Davis, maps out the physiology of the eye and its role in sending images to the brain; Kuldev Singh, Director of the Glaucoma Service at Stanford University School of Medicine, describes the symptoms of glaucoma as well as the different therapies available; and Richard Abbot, clinical professor of ophthalmology at the University of California, San Francisco, describes macular degeneration and its contributing factors."@en
This is a placeholder reference for a Organization entity, related to a WorldCat Entity. Over time, these references will be replaced with persistent URIs to VIAF, FAST, WorldCat, and other Linked Data resources.
This is a placeholder reference for a Topic entity, related to a WorldCat Entity. Over time, these references will be replaced with persistent URIs to VIAF, FAST, WorldCat, and other Linked Data resources.
This is a placeholder reference for a Topic entity, related to a WorldCat Entity. Over time, these references will be replaced with persistent URIs to VIAF, FAST, WorldCat, and other Linked Data resources.
This is a placeholder reference for a Topic entity, related to a WorldCat Entity. Over time, these references will be replaced with persistent URIs to VIAF, FAST, WorldCat, and other Linked Data resources.
This is a placeholder reference for a Topic entity, related to a WorldCat Entity. Over time, these references will be replaced with persistent URIs to VIAF, FAST, WorldCat, and other Linked Data resources.
Macular Degeneration prevention & control Popular Works.
This is a placeholder reference for a Topic entity, related to a WorldCat Entity. Over time, these references will be replaced with persistent URIs to VIAF, FAST, WorldCat, and other Linked Data resources.
This is a placeholder reference for a Topic entity, related to a WorldCat Entity. Over time, these references will be replaced with persistent URIs to VIAF, FAST, WorldCat, and other Linked Data resources.